Latest News

Elimination of health equity research funding undermines evidence base for addressing healthcare disparities and structural inequalities.

Elimination of surveillance funding creates blind spots in disease tracking and health equity measurement.

Proposed Medicaid cuts and work requirements threaten coverage for millions including people living with HIV.

Q1 2025 Watch: comprehensive update on HIV/HCV co-infection treatment access across federal and state programs.

FTC investigation confirms pharmacy benefit managers extracted billions in excess revenue through specialty drug markup schemes.

DoxyPEP post-exposure prophylaxis demonstrates effectiveness for STI prevention with implementation challenges and equity concerns.

Insurance companies deploy AI algorithms for automated prior authorization denials, restricting patient access to prescribed treatments.

Pragmatic approach to healthcare policy reform requires accepting incremental progress while maintaining advocacy commitment.

Reflection on advocacy values and health equity commitment during political transitions.

Healthcare policy opportunities and threats during lame duck congressional session.

CDC progress data on STI and overdose prevention initiatives shows mixed results.

World AIDS Day reflection on ending the HIV epidemic: challenges and opportunities.

Bipartisan HCV elimination legislation analysis and critical legislative window.

Partisan political battles threaten essential public health programs and HIV funding.

Pugh reflects on 340B policy and patient advocacy in ensuring equitable medication access.

Q4 2024 Watch: HCV treatment access assessment with guidance for disaster-displaced individuals.

Proposed Cigna-Humana merger implications for healthcare competition and access.

Call to action for community input on federal health policy initiatives.

Federal policy failures on copay accumulator programs restrict patient assistance benefits.

FTC complaint against major PBMs for anticompetitive rebating and insulin pricing.